After Plunging 12.0% in 4 Weeks, Here's Why the Trend Might Reverse for ResMed (RMD)

ResMed is currently trading in technically oversold territory, suggesting recent selling pressure may have exhausted. Broad agreement among Wall Street analysts on upward revisions to earnings estimates raises the probability of a trend reversal; monitor continued estimate revisions and price/volume confirmation for potential near-term stock appreciation.

Analysis

ResMed is currently trading in technically oversold territory, suggesting recent selling pressure may have exhausted. Broad agreement among Wall Street analysts on upward revisions to earnings estimates raises the probability of a trend reversal; monitor continued estimate revisions and price/volume confirmation for potential near-term stock appreciation.